Back to results
US 12,685,731 B2Granted
Organic compounds
AssigneeIntra-Cellular Therapies, Inc.
InventorsPeng Li, Robert Davis
Life of this patent
Estimating the term…
Abstract
The invention relates to particular substituted deuterated heterocycle fused gamma-carbolines, their prodrugs, in free, solid, pharmaceutically acceptable salt and/or substantially pure form as described herein, pharmaceutical compositions thereof, and methods of use in the treatment of diseases involving 5-HT2A receptor, serotonin transporter (SERT) and/or pathways involving dopamine D1/D2 receptor signaling systems, and/or the treatment of residual symptoms.
Claims15
A compound of formula II,
- wherein R1 and R2 are both D, in solid mono-tosylate salt form.
Dependencies are inferred from the claim text.